SEGALL BRYANT & HAMILL, LLC - BALCHEM CORP ownership

BALCHEM CORP's ticker is BCPC and the CUSIP is 057665200. A total of 257 filers reported holding BALCHEM CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SEGALL BRYANT & HAMILL, LLC ownership history of BALCHEM CORP
ValueSharesWeighting
Q3 2023$36,271,281
-10.5%
292,416
-2.8%
0.42%
-0.9%
Q2 2023$40,546,130
+121306.5%
300,765
+13.9%
0.42%
+17.8%
Q1 2023$33,397
+6.9%
264,052
+3.2%
0.36%
+3.2%
Q4 2022$31,238
-99.9%
255,825
-2.9%
0.35%
-8.6%
Q3 2022$32,035,000
-6.6%
263,553
-0.3%
0.38%
-1.0%
Q2 2022$34,285,000
-6.5%
264,248
-1.5%
0.39%
+10.0%
Q1 2022$36,662,000
-18.9%
268,1980.0%0.35%
-16.0%
Q4 2021$45,222,000
-42.3%
268,198
-50.3%
0.42%
+10.9%
Q3 2021$78,356,000
+107.5%
539,896
+87.7%
0.38%
+3.0%
Q2 2021$37,759,000
-7.6%
287,643
-11.7%
0.37%
-9.4%
Q1 2021$40,845,000
+21.2%
325,715
+11.4%
0.40%
+7.7%
Q4 2020$33,693,000
+17.5%
292,402
-0.4%
0.38%
-3.6%
Q3 2020$28,665,000
+7.8%
293,556
+4.7%
0.39%
-13.0%
Q2 2020$26,582,000
-10.2%
280,383
-6.5%
0.45%
-25.7%
Q1 2020$29,613,000
-3.3%
299,974
-0.5%
0.60%
+26.7%
Q4 2019$30,634,000
+0.8%
301,550
-1.5%
0.48%
+0.6%
Q3 2019$30,377,000
-3.9%
306,140
-3.1%
0.47%
-1.0%
Q2 2019$31,597,000
+1.9%
316,094
-5.4%
0.48%
-1.0%
Q1 2019$31,016,000
+18.0%
334,142
-0.4%
0.48%
+6.4%
Q4 2018$26,288,000
-34.4%
335,525
-6.1%
0.45%
-23.2%
Q3 2018$40,048,000
+13.2%
357,284
-0.9%
0.59%
+9.5%
Q2 2018$35,383,000
+16.5%
360,540
-3.0%
0.54%
-23.4%
Q1 2018$30,383,000
-0.6%
371,654
-2.0%
0.70%
+4.6%
Q4 2017$30,580,000
-3.5%
379,402
-2.7%
0.67%
-8.6%
Q3 2017$31,682,000
+4.2%
389,739
-0.4%
0.74%
+2.8%
Q2 2017$30,395,000
-10.9%
391,138
-5.5%
0.72%
-13.1%
Q1 2017$34,115,000
-1.9%
413,913
-0.2%
0.82%
-5.6%
Q4 2016$34,791,000
+6.7%
414,577
-1.4%
0.87%
+4.4%
Q3 2016$32,598,000
+34.3%
420,461
+3.3%
0.84%
+30.6%
Q2 2016$24,272,000
-10.3%
406,908
-6.7%
0.64%
-4.5%
Q1 2016$27,051,000
-5.9%
436,166
-7.8%
0.67%
-3.0%
Q4 2015$28,752,000
-9.0%
472,899
-9.1%
0.69%
-10.3%
Q3 2015$31,612,000
-5.1%
520,189
-13.0%
0.77%
+3.4%
Q2 2015$33,300,000
-6.9%
597,628
-7.4%
0.74%
-7.3%
Q1 2015$35,757,000
-26.3%
645,662
-11.3%
0.80%
-26.6%
Q4 2014$48,499,000
+16.1%
727,773
-1.5%
1.10%
+13.4%
Q3 2014$41,787,000
+5.1%
738,673
-0.5%
0.97%
+2.0%
Q2 2014$39,776,000
-51.6%
742,635
-52.9%
0.95%
-3.6%
Q1 2014$82,196,000
-9.5%
1,577,056
+2.0%
0.98%
-7.9%
Q4 2013$90,802,000
+117.0%
1,546,890
+91.3%
1.07%
+3.1%
Q3 2013$41,847,000
+11.4%
808,641
-3.7%
1.03%
+4.3%
Q2 2013$37,568,000
-4.6%
839,510
-6.3%
0.99%
-5.3%
Q1 2013$39,387,000896,3821.05%
Other shareholders
BALCHEM CORP shareholders Q4 2020
NameSharesValueWeighting ↓
SANTA MONICA PARTNERS LP 353,431$59,588,00037.96%
Conestoga Capital Advisors, LLC 1,000,708$168,719,0002.20%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 71,969$12,134,0001.86%
Tributary Capital Management, LLC 140,224$23,642,0001.78%
GENEVA CAPITAL MANAGEMENT LLC 651,326$109,813,0001.77%
Cutter & CO Brokerage, Inc. 33,549$5,656,0001.55%
WASATCH ADVISORS LP 1,693,842$285,582,0001.16%
MOODY ALDRICH PARTNERS LLC 49,518$8,349,0001.16%
ICW Investment Advisors LLC 10,875$1,834,0001.02%
Kensington Investment Counsel, LLC 9,074$1,530,0000.89%
View complete list of BALCHEM CORP shareholders